Semin intervent Radiol 2004; 21(4): 335-343
DOI: 10.1055/s-2004-861568
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Interventional Procedures in Whole Organ and Islet Cell Pancreas Transplantation

Barry Daly1 , Kevin O'Kelly2 , David Klassen3
  • 1Department of Diagnostic Radiology, University of Maryland, Baltimore, Maryland
  • 2Department of Diagnostic Radiology, University of Alberta, Edmonton, Alberta, Canada
  • 3Department of Medicine, University of Maryland, Baltimore, Maryland
Further Information

Publication History

Publication Date:
07 January 2005 (online)

ABSTRACT

Pancreas organ transplantation has been a therapeutic option for the treatment of diabetes mellitus for over a decade. More recently, percutaneous injection of isolated pancreas islet cells via the portal vein has been developed as an exciting minimally invasive alternative procedure to whole organ transplantation, and one where the interventional radiologist may play a major role. This chapter reviews the role of image guided intervention in the whole organ pancreas transplant and describes the evolving technique of percutaneous islet cell transplantation.

REFERENCES

  • 1 Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.  N Engl J Med. 1993;  329 977-986
  • 2 Laing S P, Swerdlow A J, Slater S D et al.. The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus.  Diabet Med. 1999;  16 466-471
  • 3 Sutherland D E, Gruessner R W, Dunn D L et al.. Lessons learnt from more than 1,000 pancreas transplants at a single institution.  Ann Surg. 2001;  233 463-501
  • 4 Marks W H, Borgstrom A, Marks C R, Sollinger H, Lorber M I. Serum markers for pancreas rejection: long-term behavior following clinical pancreatico-duodenal transplantation.  Transplant Proc. 1991;  23 1596-1597
  • 5 Perkal M, Marks C, Lorber M I, Marks W H. A three-year experience with serum anodal trypsinogen as a biochemical marker for rejection in pancreatic allografts. False positives, tissue biopsy, comparison with other markers, and diagnostic strategies.  Transplantation. 1992;  53 415-419
  • 6 Klassen D K, Weir M R, Cangro C B, Bartlett S T, Papadimitriou J C, Drachenberg C B. Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience.  Transplantation. 2002;  73 553-555
  • 7 Warnock G L, Kneteman N M, Ryan E A, Seelis R EA, Rabinovitch A, Rajotte R V. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 diabetes.  Diabetologia. 1991;  34 55-58
  • 8 Shapiro A M, Lakey J R, Ryan E A et al.. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen.  N Engl J Med. 2000;  343 230-238
  • 9 Allen R D, Wilson T G, Grierson J M et al.. Percutaneous biopsy of bladder-drained pancreas transplants.  Transplantation. 1991;  51 1213-1216
  • 10 Douzdjian V, Cooper J, Abecassis M, Corry R. Markers for pancreatic allograft rejection: comparison of serum anodal trypsinogen amylase, serum creatinine and urinary amylase.  Clin Transplant. 1994;  8 79-82
  • 11 Wong J J, Krebs T L, Klassen D K et al.. Sonographic evaluation of acute pancreatic transplant rejection: morphology-Doppler analysis versus guided percutaneous biopsy.  AJR Am J Roentgenol. 1996;  166 803-807
  • 12 Krebs T L, Daly B, Wong-You-Cheong J J, Carroll K, Bartlett S T. Acute pancreatic transplant rejection: evaluation with dynamic contrast-enhanced MR imaging compared with histopathologic analysis.  Radiology. 1999;  210 437-442
  • 13 Klassen D K, Hoen-Saric E W, Weir M R et al.. Isolated pancreas rejection in combined kidney pancreas tranplantation.  Transplantation. 1996;  61 974-977
  • 14 Bartlett S T, Schweitzer E J, Johnson L B et al.. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.  Ann Surg. 1996;  224 440-449
  • 15 Laftavi M R, Gruessner A C, Bland B J et al.. Diagnosis of pancreas rejection: cystoscopic transduodenal versus percutaneous computed tomography scan-guided biopsy.  Transplantation. 1998;  65 528-532
  • 16 Atwell T, Gorman B, Larson T et al.. Pancreas Transplants: Experience with 232 percutaneous US-guided biopsy procedures in 88 patients.  Radiology. 2004;  231 845-849
  • 17 Drachenberg C B, Papadimitriou J C, Klassen D K et al.. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system.  Transplantation. 1997;  63 1579-1586
  • 18 Drachenberg C B, Klassen D K, Weir M R et al.. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.  Transplantation. 1999;  68 396-402
  • 19 Papadimitriou J C, Drachenberg C B, Klassen D K et al.. Histological grading of chronic pancreas allograft rejection/graft sclerosis.  Am J Transplant. 2003;  3 599-605
  • 20 Drachenberg C B, Abruzzo L V, Klassen D K et al.. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.  Hum Pathol. 1998;  29 569-577
  • 21 Klassen D K, Drachenberg C B, Papadimitriou J C et al.. CMV allograft pancreatitis: diagnosis, treatment, and histological features.  Transplantation. 2000;  69 1968-1971
  • 22 Aideyan O A, Schmidt A J, Trenkner S W, Hakim N S, Gruessner R W, Walsh J W. CT-guided percutaneous biopsy of pancreas transplants.  Radiology. 1996;  201 825-828
  • 23 Krebs T, Wong-You-Cheong J, Daly B. Pancreatic transplantation imaging. In: Gore RM, Levine MS Textbook of Gastrointestinal Radiology. 2nd ed Philadelphia; WB Saunders 2000
  • 24 Letourneau J G, Hunter D W, Crass J R, Thompson W M, Sutherland D E. Percutaneous aspiration and drainage of abdominal fluid collections after pancreatic transplantation.  AJR Am J Roentgenol. 1988;  150 805-809
  • 25 Patel B K, Garvin P J, Aridge D L, Chenoweth J L, Markivee C R. Fluid collections developing after pancreatic transplantation: radiologic evaluation and intervention.  Radiology. 1991;  181 215-220
  • 26 Norstein J, Brekke I B, Holdaas H, Vatne K. Arterial stenoses in duct occluded segmental pancreatic grafts treated with percutaneous transluminal angioplasty.  Transplant Proc. 1990;  22 599-601
  • 27 Abdalla E K, Hicks M E, Vauthey J N. Portal vein embolization: rationale, technique and future prospects.  Br J Surg. 2001;  88(7) 165-175
  • 28 Owen J T, Ryan E A, O’Kelly K et al.. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects.  Radiology. 2003;  229 165-170
  • 29 Ryan E A, Lakey J R, Rajotte R V et al.. Clinical Outcomes and Insulin Secretion after Islet Transplantation with the Edmonton Protocol.  Diabetes. 2001;  50(4) 710-719
  • 30 Shapiro A M, Lakey J R, Ryan E A et al.. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen.  N Engl J Med. 2000;  343 230-238
  • 31 Bucher P, Mathe Z, Bosco D et al.. Morbidity Associated With Intraportal Islet Cell Transplantation. Proceedings of IPITA Congress Dublin; 2003 (Published on-line). (www.ipita.org/abstracts/2003_060_066.htm)

Barry DalyM.D. 

Department of Diagnostic Radiology, University of Maryland Medical Center

22 S. Greene Street

Baltimore, MD 21201-1595